STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM has added 75,851 shares of $HIMS to their portfolio, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 03-31-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $HIMS.
HIMS & HERS HEALTH Hedge Fund Activity
We have seen 240 institutional investors add shares of HIMS & HERS HEALTH stock to their portfolio, and 203 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FARALLON CAPITAL MANAGEMENT LLC added 8,364,000 shares (+64338.5%) to their portfolio in Q4 2024, for an estimated $202,241,520
- BLACKROCK, INC. removed 5,862,886 shares (-19.5%) from their portfolio in Q1 2025, for an estimated $173,248,281
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 4,145,305 shares (+192.0%) to their portfolio in Q4 2024, for an estimated $100,233,474
- STATE STREET CORP added 3,146,380 shares (+68.0%) to their portfolio in Q4 2024, for an estimated $76,079,468
- ICONIQ CAPITAL, LLC added 2,874,769 shares (+inf%) to their portfolio in Q4 2024, for an estimated $69,511,914
- GOLDMAN SACHS GROUP INC added 2,738,501 shares (+49.4%) to their portfolio in Q1 2025, for an estimated $80,922,704
- INSTITUTIONAL VENTURE MANAGEMENT XVI, LLC removed 2,628,682 shares (-60.5%) from their portfolio in Q4 2024, for an estimated $63,561,530
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
HIMS & HERS HEALTH Insider Trading Activity
HIMS & HERS HEALTH insiders have traded $HIMS stock on the open market 141 times in the past 6 months. Of those trades, 2 have been purchases and 139 have been sales.
Here’s a breakdown of recent trading of $HIMS stock by insiders over the last 6 months:
- ANDREW DUDUM (Chief Executive Officer) has made 0 purchases and 42 sales selling 1,069,824 shares for an estimated $38,700,038.
- MELISSA BAIRD (Chief Operating Officer) has made 0 purchases and 28 sales selling 414,042 shares for an estimated $13,030,935.
- OLUYEMI OKUPE (Chief Financial Officer) has made 0 purchases and 29 sales selling 360,655 shares for an estimated $10,848,741.
- SOLEIL BOUGHTON (Chief Legal Officer) has made 0 purchases and 13 sales selling 353,166 shares for an estimated $10,191,707.
- MICHAEL CHI (Chief Commercial Officer) has made 0 purchases and 16 sales selling 152,768 shares for an estimated $5,042,482.
- DAVID B WELLS sold 40,000 shares for an estimated $1,199,584
- IRENE BECKLUND (PAO) has made 0 purchases and 8 sales selling 29,488 shares for an estimated $978,766.
- PATRICK HARRISON CARROLL (Chief Medical Officer) has made 0 purchases and 2 sales selling 27,994 shares for an estimated $931,902.
- ANJA MANUEL has made 2 purchases buying 5,000 shares for an estimated $132,259 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
HIMS & HERS HEALTH Analyst Ratings
Wall Street analysts have issued reports on $HIMS in the last several months. We have seen 2 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Sell" rating on 05/06/2025
- Needham issued a "Buy" rating on 02/25/2025
- Canaccord Genuity issued a "Buy" rating on 02/19/2025
To track analyst ratings and price targets for HIMS & HERS HEALTH, check out Quiver Quantitative's $HIMS forecast page.
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $HIMS ticker page for more data.
